Arrowhead Pharmaceuticals Inc.

NASDAQ:ARWR 4:00:00 PM EDT

36.12

+1.12 (+3.20%)

7:41:44 PM EDT: $36.30 +0.18 (+0.50%)

Market Cap (Intraday)	3.86B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$44.79 Million
Adjusted EPS	-$0.60

See more estimates

10-Day MA	$35.50
50-Day MA	$33.32
200-Day MA	$33.35

See more pivots

Arrowhead Pharmaceuticals Inc. Stock, NASDAQ:ARWR

177 East Colorado Boulevard, Suite 700, Pasadena, California 91105

United States of America

Phone: +1.626.304.3400

Number of Employees: 397

http://www.arrowheadpharma.com

Description

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.